These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3190999)

  • 1. Quinapril and blood lipids.
    Koskinen P; Manninen V; Eisalo A
    Br J Clin Pharmacol; 1988 Oct; 26(4):478-80. PubMed ID: 3190999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
    Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
    J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril.
    Manzato E; Capurso A; Crepaldi G
    J Int Med Res; 1993; 21(1):15-25. PubMed ID: 8319817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
    Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive drugs on blood pressure and metabolic alterations in the fructose-induced hypertensive rat.
    Navarro-Cid J; Maeso R; Perez-Vizcaino F; Casal MC; Cachofeiro V; Ruilope LM; Tamargo J; Lahera V
    Am J Hypertens; 1996 Jul; 9(7):669-74. PubMed ID: 8806979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.
    London GM; Pannier B; Vicaut E; Guérin AP; Marchais SJ; Safar ME; Cuche JL
    J Hypertens; 1996 Sep; 14(9):1139-46. PubMed ID: 8986916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function.
    Wilmink HW; Banga JD; Hijmering M; Erkelens WD; Stroes ES; Rabelink TJ
    J Am Coll Cardiol; 1999 Jul; 34(1):140-5. PubMed ID: 10400003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged inhibition of local angiotensin-converting enzyme after single or repeated treatment with quinapril in spontaneously hypertensive rats.
    Nakajima T; Yamada T; Setoguchi M
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):102-7. PubMed ID: 1375675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
    Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation.
    Suwelack B; Gerhardt U; Hausberg M; Rahn KH; Hohage H
    Am J Cardiol; 2000 Sep; 86(5):583-5, A10. PubMed ID: 11009288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of quinapril and losartan on insulin sensitivity in genetic hypertensive rats with different metabolic abnormalities.
    Nakagawa H; Daihara M; Tamakawa H; Nozue T; Kawahara K
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):28-33. PubMed ID: 10413063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
    Kjeldsen SE; Gupta RK; Krause L; Weder AB; Julius S
    Am Heart J; 1992 May; 123(5):1433-8. PubMed ID: 1575171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.
    Gupta RK; Kjeldsen SE; Krause L; Kneisley J; Posvar E; Weder AB; Julius S
    Clin Pharmacol Ther; 1990 Jul; 48(1):41-9. PubMed ID: 2196144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.
    MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL
    Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood lipid changes in hypertensive, dyslipidemic patients under long term quinapril treatment.
    Cangelosi MM; Gaudio M; Brancati AM; Leggio F
    Int Angiol; 1994 Mar; 13(1):65-7. PubMed ID: 8077801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise.
    Cléroux J; Beaulieu M; Kouamé N; Lacourcière Y
    Am J Hypertens; 1994 Jun; 7(6):566-70. PubMed ID: 7917158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats.
    Graziano MJ; Dethloff LA; Griffin HE; Pegg DG
    Arch Int Pharmacodyn Ther; 1993; 324():87-104. PubMed ID: 8297189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?
    Palatini P
    Am Heart J; 1992 May; 123(5):1421-5. PubMed ID: 1575169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats.
    Albaladejo P; Bouaziz H; Duriez M; Gohlke P; Levy BI; Safar ME; Benetos A
    Hypertension; 1994 Jan; 23(1):74-82. PubMed ID: 8282333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.